Christopher O’Callaghan

9.6k citations
254 papers · 13.9k · 5 hit papers · h-index 61

Impact in

Papers in

Christopher O’Callaghan

245 papers receiving 13.1k citations

Christopher O’Callaghan's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+5+11Years since publication5001k1.5k

Peers

Christopher O’Callaghan
Comparison fields: 5 of 168
  • Pulmonary and Respiratory Medicine 6k
  • Infectious Diseases 2.5k
  • Genetics 1.5k
  • Microbiology 228
  • Physiology 889
Replace Scott H. Randell with:
Scott H. Randell United States
Robert Wilson United Kingdom
Marcus Alexander Mall Germany
Kenneth N. Olivier United States
Anthony De Soyza United Kingdom
Paul B. McCray United States
Georges E. Grau Australia
Michael R. Loebinger United Kingdom
David Kyle Meyerholz United States
Taco Willem Kuijpers Netherlands
Christopher O’Callaghan relative to Scott H. Randell United States Scott H. Randell's profile →
Citations per field
00.5×1.5×
Scott H. Randell · 1×
Citations per year

Countries citing papers authored by Christopher O’Callaghan

Since Specialization
Citations

This map shows the geographic impact of Christopher O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher O’Callaghan more than expected).

Fields of papers citing papers by Christopher O’Callaghan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher O’Callaghan. The network helps show where Christopher O’Callaghan may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher O’Callaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher O’Callaghan Line = papers co-authored together Christopher O’Callaghan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
20211531
2
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
3
Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children
Hit paper breakdown →
2009408
4
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021393
5 1998308
6 2009289
7 2010284
8
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
9 2007271
10 1997256
11 2021240
12 2012231
13 2008220
14 2021213
15 2012211
16 2014201
17 2016178
18 2004171
19 2012165
20 2010164

About Christopher O’Callaghan

Christopher O’Callaghan is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Epidemiology, Physiology and Microbiology, having authored 254 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (78 papers), Inhalation and Respiratory Drug Delivery (63 papers), Genetic and Kidney Cyst Diseases (24 papers), Asthma and respiratory diseases (18 papers), Respiratory viral infections research (12 papers), Pneumonia and Respiratory Infections (11 papers), Bacterial Infections and Vaccines (10 papers) and Cerebrospinal fluid and hydrocephalus (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6k citations), Infectious Diseases (2.5k citations), Genetics (1.5k citations), Microbiology (228 citations) and Physiology (889 citations). Christopher O’Callaghan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert Anthony Hirst, Peter W. Barry, Andrew Rutman, Anthony David Milner, PW Barry, P W Barry, Peter William Andrew, Andrew Bush, Alexander Swarbrick and Mark A. Chilvers. Their work appears in journals such as European Respiratory Journal, Archives of Disease in Childhood, Thorax, The Lancet and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact